Healthtech Startups

SleepSpace provides a digital platform with expert-written content and practical guidance on sleep improvement, sleep disorders, and cognitive behavioral therapy for insomnia. The platform offers tutorials and integrates with wearable devices to help users optimize sleep quality.

2 investors

smallTalk develops technology products that support early childhood brain development through language exposure. The company targets parents and caregivers of infants and young children in the early development market.

2 investors

SMARTCharts provides software that extracts rehabilitation data from clinical notes to accelerate hospital discharge planning and coordination among physicians, therapists, and case managers. The platform uses AI to track therapy progress and generate automated insights for healthcare providers managing patient rehabilitation.

2 investors

SmartCatch develops compact microfiltration devices that isolate Circulating Tumor Cells (CTCs) directly from whole blood without pre-analytical steps, enabling liquid biopsy for cancer diagnosis and monitoring. Its products target clinicians, pharmaceutical companies, and researchers in medical oncology and precision medicine.

2 investors

Smart Cells stores and processes umbilical cord blood and tissue containing stem cells for families in the UK, offering banking services for potential future medical use. The company is part of Europe's largest stem cell bank and operates with full regulatory licensing and approval.

2 investors

Smile Doctors operates a network of orthodontic practices that provide customized treatment plans, including braces and aligners, for children, teens, and adults. The company offers services such as comprehensive exams with X-rays and orthodontist-monitored treatment across its U.S. locations.

2 investors

Smiletronix, based in Barcelona, has developed a handheld intraoral imaging device paired with a mobile app for at-home dental examinations. The system is intended to let patients capture and monitor the state of their teeth without visiting a clinic for each check-up.

2 investors

Smileyscope develops virtual reality digital therapeutics for clinical procedures that reduce patient pain and anxiety without sedation. The platform is used by healthcare organizations to manage procedural pain and anxiety across various medical settings.

2 investors

Sobrera Pharma is a life science pharmaceutical company developing treatments for alcohol abuse, founded by researchers and clinicians from the Sahlgrenska Academy, University of Gothenburg.

2 investors

Softheon provides technology for health insurance plans and government agencies to manage shopping, enrollment, billing, payments, and analytics across ACA Marketplace, Medicare Advantage, and ICHRA coverage. The company serves health plans and state and federal agencies in the United States within the health insurance and healthtech sector.

2 investors

Sofwave develops non-invasive medical aesthetic devices using next-generation technology for skin revitalization, muscle toning, and facial treatments. The company serves aesthetic practices and clinics seeking FDA-cleared solutions for wrinkle reduction, skin laxity, and body contouring.

2 investors

SoGal Ventures is a women-led venture capital firm that invests in and co-creates consumer, health, and future-of-work startups, with a focus on underrepresented founders, undercapitalized geographies, and underserved problems.

2 investors

Soihtu DTx develops a clinical-stage digital therapeutic delivered as a narrative-driven video game designed to treat depression. The product is personalized using precision psychiatry principles and has been validated in large-scale clinical trials.

2 investors

Soker Data provides health datasets from diverse populations to train AI models and support clinical trial decisions. The company addresses data bias in healthcare by curating datasets for pharmaceutical companies, AI developers, and clinical research organizations.

2 investors

Solabia is a producer of raw materials including ingredients, active ingredients, culture media, and diagnostic kits for the cosmetics, pharmaceutical, nutraceutical, and biotechnology industries. The group serves manufacturers in these sectors with a focus on innovation, sustainability, and responsible growth.

2 investors

Solaxa is a biotech company developing pharmacological and cell-based treatments for peripheral nerve injury and spinal cord injury, drawing on regenerative medicine and nerve technologies. It focuses on drug and drug-device combination products in the field of neurology.

2 investors

Soleo Health is a national provider of complex specialty pharmacy services, delivering high-cost therapies at home or alternate sites of care with support from clinical pharmacists, nurses, and reimbursement specialists. It works with pharmaceutical manufacturers, health plans, and providers to serve patients requiring focused clinical monitoring and infusion care.

2 investors

Solgate is a drug discovery company developing small-molecule drugs that target solute carrier (SLC) membrane transporter proteins, using a platform combining chemical, biological, and computational technologies. A spin-off from CeMM/ÖAW and IST Austria, it focuses on advancing a pipeline of SLC-targeting compounds toward clinical development for human disease.

2 investors

Soliddd is an optical and vision technology company developing a low-vision aid for people with macular degeneration, using autostereo 3D optics that let the visual cortex perceive 3D to restore sight in previously blind areas of the visual field. The product is in pre-clinical testing and targets patients with macular degeneration and other vision conditions.

2 investors

Solmetex provides water management systems for dental practices, including amalgam collection, disposal and recycling, waterline testing, and compliance tracking with the EPA Dental Amalgam Rule. Operating since 1996, it serves dental offices worldwide through its Solmetex, Sterisil, and DryShield brands.

2 investors

Solstice Oncology is a clinical-stage immuno-oncology company developing porustobart, a second-generation engineered CTLA-4 antibody given with anti–PD-1 therapy in the neoadjuvant (pre-surgery) setting to treat early-stage cancers. Its lead program targets microsatellite-stable stage III colon cancer, with additional early-stage solid tumor programs.

2 investors

Solstice is a health-focused company working on improving medicine, positioning itself around solving difficult problems in the space. The page is a careers/values page and provides limited detail about specific products or services.

2 investors

Solu provides a cloud-based genomic surveillance platform that analyzes microbial genomes in real-time without requiring coding or configuration. The platform serves public health institutions, research labs, and medical centers performing pathogen sequencing, outbreak detection, and antimicrobial resistance monitoring.

2 investors

Solu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.

2 investors